medigraphic.com
ISSN 0326-3428 (Print)
Órgano de difusión científica de la Asociación Nefrológica de Buenos Aires

2020, Number 4

<< Back Next >>

Rev Nefrol Dial Traspl 2020; 40 (4)

Living Donor Kidney Transplantation: Why Potential Donors and Recipients do not Achieve it. Malatya Algorithm

Simsek A, Murat DS, Gurbuz H, Ulutas O, Toplu S, Turgut A, Okan YI, Bayindir Y, Taskapan H, Sahin I, Unal B, Piskin T

Language: English
References: 10
Page: 304-310
PDF size: 307.68 Kb.


ABSTRACT

Introduction: In some countries, organ donation is not widespread enough due to medical, cultural, ethical and socioeconomic factors. Living-donor kidney transplant constitutes the main source of kidney donation. Aim: To evaluate the causes of cancellation of living-donor kidney transplant and improve the effectiveness of transplant programs. Methods: Medical records of possible donors and recipients who were evaluated for living-donor kidney transplant at a tertiary medical center between November 2010 and September 2019 were reviewed retrospectively. Results: Evaluations were performed on 364 potential donors and 338 living-donor kidney transplant recipients; 207 of the latter (61.24%) underwent livingdonor kidney transplant. Immune disorders represented the majority of cancellations (38.84%). Fiftysix donors (15.38%) were rejected mainly due to renal disorders (39%). Conclusion: Timely referral of patients to transplant centers must be guaranteed in order to overcome immune problems. Transplant centers should invest in programs adequate both for their resources and for their patients: paired kidney exchange, desensitization protocols, future research, etc.


REFERENCES

  1. Schena FP. Epidemiology of end‐stage renal disease:international comparisons of renal replacementtherapy. Kidney Int. 2000;57(Suppl. 74):S39-S45. doi:10.1046/j.1523-1755.2000.07407.x

  2. Global Observatory on Donation and Transplantation.International report on organ donation andtransplantation activities, executive summary 2017[Internet]. Disponible en: (consulta: 25/03/2020).

  3. OPTN/UNOS (Organ Procurement andTransplantation Network)/United Network for OrganSharing) National Data Reports, Transplants byDonor Type, latest data 2017 [Internet]. Disponibleen: (consulta: 25/03/2020).

  4. Ciszek M, Pączek L, Łuków P, Rowiński W. Effectiveoptimization of living donor kidney transplantationactivity ensuring adequate donor safety. Ann Transplant.2012;17(3):103-10. doi: 10.12659/aot.883464.

  5. Friedman AL, Peters TG, Jones KW, BoulwareLE, Ratner LE. Fatal and nonfatal hemorrhagiccomplications of living kidney donation. AnnSurg. 2006;243(1):126-30. doi: 10.1097/01.sla.0000193841.43474.ec.

  6. Muzaale AD, Massie AB, Wang MC, Montgomery RA,McBride MA, L Wainrigh JL, et al. Risk of end-stagerenal disease following live kidney donation. JAMA.2014;311(6):579-86. doi: 10.1001/jama.2013.285141.

  7. Mjøen G, Hallan S, Hartmann A, Foss A, MidtvedtK, Øyen O, et al. Long-term risks for kidney donors.Kidney Int. 2014;86(1):162-7. doi: 10.1038/ki.2013.460.

  8. Ethics Committee of the Transplantation Society.The consensus statement of the AmsterdamForum on the Care of the Live Kidney Donor.Transplantation. 2004;78(4):491-2. doi: 10.1097/01.tp.0000136654.85459.1e.

  9. Turkish Transplantation Foundation. [Statistics,2002-2018 Turkey tables and graphs related to organdonation and transplantation] [Internet]. Disponibleen: (consulta: 25/03/2020).

  10. Council of Europe Reference Documents; EuropeanDirectorate for the Quality of Medicines. KidneyExchange Programmes in Europe Position Paper of theCouncil of Europe European Committee on OrganTransplantation (CD-P-TO). Newsletter Transplant.2018;23(1):76-80.




2020     |     www.medigraphic.com